Cargando…
Changes in Recombinant Human Bone Morphogenetic Protein-2 Use in Posterior Fusion Over the Past Two Decades
Background In 2011, studies suggested that complications and cancer rates associated with bone morphogenetic protein (BMP) were greater than previously reported. However, later studies reported complication rates similar to prior literature and no increased cancer rate. We evaluated the pattern of c...
Autores principales: | Nabizadeh, Naveed, Glassman, Steven D, Djurasovic, Mladen, Crawford, Charles H, Gum, Jeffrey L, Carreon, Leah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525685/ https://www.ncbi.nlm.nih.gov/pubmed/34692284 http://dx.doi.org/10.7759/cureus.18055 |
Ejemplares similares
-
Predictors of segmental lumbar lordosis following midline posterior (transforaminal) lumbar interbody fusion: Does interbody device type matter?
por: Crawford, Charles H, et al.
Publicado: (2022) -
Neurologic Disease Is a Risk Factor for Revision After Lumbar Spine
Fusion
por: Glassman, Steven D., et al.
Publicado: (2019) -
Minimally-Invasive midline posterior interbody fusion with cortical bone trajectory screws compares favorably to traditional open transforaminal interbody fusion
por: Crawford, Charles H., et al.
Publicado: (2019) -
The Effect of Symptom Duration on Outcomes After Fusion for Degenerative Spondylolisthesis
por: Fleming, John, et al.
Publicado: (2018) -
Postoperative Cyst Associated with Bone Morphogenetic Protein Use in Posterior and Transforaminal Lumbar Interbody Fusion Managed Conservatively: Report of Two Cases
por: Baron, Eli M, et al.
Publicado: (2016)